Taytulla NDC 0023-5862

NDC codes

FDA NDC Directory

Product NDC (as listed)0023-5862Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00023-5862Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
0023-5862-29	00023586229	1 BLISTER PACK in 1 CARTON (0023-5862-29) / 1 KIT in 1 BLISTER PACKMarketed from May 1, 2016 · Sample package
0023-5862-30	00023586230	5 CARTON in 1 TRAY (0023-5862-30) / 1 BLISTER PACK in 1 CARTON (0023-5862-28) / 1 KIT in 1 BLISTER PACKMarketed from May 1, 2016
0023-5862-31	00023586231	6 CARTON in 1 TRAY (0023-5862-31) / 6 BLISTER PACK in 1 CARTON / 1 KIT in 1 BLISTER PACKMarketed from May 1, 2016 · Sample package

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Taytulla
Generic name (nonproprietary): norethindrone acetate and ethinyl estradiol, and ferrous fumarate
Dosage form: Kit
Labeler: Allergan, Inc.
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 204426
Marketing start: May 1, 2016
Listing expires: Dec 31, 2027
Identifiers: Product ID 0023-5862_031c2733-dbb1-443e-a5ec-4ce36d995402SPL ID 031c2733-dbb1-443e-a5ec-4ce36d995402SPL set ID 2fa8e8dc-f7b0-429a-b554-0e3c4291c92cRxCUI 1421459, 1421460, 1421461, 1809905

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N400023586229 followed by a unit qualifier and the quantity

Package 00023-5862-29. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 25, 2024. This label includes a boxed warning.

Indications (excerpt from the label)

1 INDICATION S AND USAGE TAYTULLA is indicated for use by females of reproductive age to prevent pregnancy [ see Clinical Studies (14) ] . The efficacy of TAYTULLA in women with a body mass index (BMI) of more than 35 kg/m 2 has not been evaluated. TAYTULLA is a combination of norethindrone acetate, a progestin, and ethinyl estradiol, an estrogen, indicated for use by females of reproductive potential to prevent pregnancy ( 1 ) The efficacy of TAYTULLA in females of reproductive potential with a body mass index (BMI) of > 35 kg/m 2 has not been evaluated ( 1 , 8.8 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)